ethyl 2,2-difluoro-1-(4-(trifluoromethoxy)phenyl)cyclopropane-1-carboxylate - Names and Identifiers
ethyl 2,2-difluoro-1-(4-(trifluoromethoxy)phenyl)cyclopropane-1-carboxylate - Introduction
ethyl 2,2-difluoro-1-(4-(trifluoromethoxy)phenyl)cyclopropane-1-carboxylate is an organic compound. The following is a description of its nature, use, formulation and safety information:
Nature:
-Appearance: colorless liquid
-Molecular formula: C14H9F5O2
-Molecular weight: 316.21g/mol
-Melting point:-20 ℃
-Boiling point: 150-152 ℃
-Density: 1.38g/cm³
-Soluble in general organic solvents at room temperature
Use:
ethyl 2,2-difluoro-1-(4-(trifluoromethoxy)phenyl)cyclopropane-1-carboxylate has good chemical stability and reactivity. Because of its special structure, it is often used as an intermediate in organic synthesis. It can be used to synthesize biologically active compounds, such as pesticides, pharmaceuticals, etc. In addition, it can also be used in research fields such as catalysts and coordination chemistry.
Method:
The preparation method of ethyl 2,2-difluoro-1-(4-(trifluoromethoxy)phenyl) cyclopane -1-carboxylate is relatively complicated, generally starting from the corresponding precursor compounds, after a multi-step reaction synthesis. The specific synthetic route varies depending on the purpose and conditions of the study.
Safety Information:
- ethyl 2,2-difluoro-1-(4-(trifluoromethoxy)phenyl)cyclopropane-1-carboxylate should be stored in a sealed container, away from fire and high temperature.
-Avoid contact with skin and eyes when using, and avoid inhaling its vapor or dust.
-Pay attention to good ventilation conditions during operation, and it is best to operate under a protective cabinet.
-In the event of accidental contact or inhalation, seek medical attention immediately and bring the compound label or packaging.
Please note that due to the complexity and potential hazards of chemicals, please read the relevant safety data sheets and operating manuals carefully before use, and operate under suitable equipment and laboratory conditions.
Last Update:2024-04-09 21:32:47